ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMA is expected to report earnings to rise 31.75% to -82 cents per share on November 11
Q3'26
Est.
$-0.83
Q2'26
Beat
by $0.32
Q1'26
Missed
by $0.75
Q4'25
Missed
by $0.11
Q2'25
Missed
by $0.55
The last earnings report on August 05 showed earnings per share of -62 cents, beating the estimate of -94 cents. With 3.21K shares outstanding, the current market capitalization sits at 45.92M.